Speaker illustration

Professor Ron Waksman

Washington Hospital Center & Medstar Health, Washington, DC (United States of America)

Member of:

European Society of Cardiology

LRT - Transcatheter Aortic Valve Replacement For Patients With Severe Aortic Stenosis Who Are At Low Risk For Mortality: Results From The Prospective Multicenter LRT Clinical Trial

Event: ESC Congress 2018

Topic: Aortic Valve Intervention

Session: Late Breaking TAVI Registries

Thumbnail

FDA: new programmes to facilitate early feasibility.

Event: ESC Congress 2018

Topic: e-Cardiology/Digital Health

Session: The effect of regulation on innovation

Thumbnail

Marketing of medical devices in the US & Europe: focus on regulatory requirements and patient access

Event: ESC Congress 2017

Topic: Miscellaneous

Session: Approval processes for medical devices - Understanding clinical and regulatory perspectives - Spotlight on coronary stents

Thumbnail

Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Event: ESC Congress 2017

Topic: Aortic valve disease

Session: Risk stratification and prognosis after TAVI

Thumbnail

Choice of balloon-expandable versus self-expanding transcatheter aortic valve impacts hemodynamics differently according to aortic annulus size

Event: ESC Congress 2016

Topic: Aortic valve disease

Session: Valvular disease

Thumbnail

SYMPLICITY HTN-3 screen failure patient cohort analysis

Event: ESC Congress 2016

Topic: Treatment of hypertension

Session: Resistant hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb